Table 7 Results of a 26-week Trial of Liraglutide Injection as add-on to Sulfonylurea in Adult Patients with Type 2 Diabetes Mellitus a Add-on to Metformin and Sulfonylurea In this 26-week trial, 581 adult patients with type 2 diabetes mellitus were randomized to liraglutide injection 1.8 mg, placebo, or insulin glargine, all as add-on to metformin and glimepiride
Integration of ER protein quality control mechanisms defines beta cell function and ER architecture
Nature 324 , 425429 (1986)
A California company, Okava Pharmaceuticals, has launched a clinical trial testing a GLP-1based weight loss treatment in 50 cats
Here are a few examples: USP 800 Compliance Cultural Competency Training Dispensing Prescriptions Off-Label Biologic Medications and Interchangeability Continuous Glucose Monitor Requirements for Medicare Part B PAAS Tips: MORE AUDITS, MORE INSIGHT PAAS National is the industry-leading defender of community pharmacy dealings with Prescription Benefit Programs, including Caremark, Express Scripts, Humana, Medicaid, OptumRx, Prime Therapeutics., and more